How much does Ceritinib (ceritinib) cost in India? Costs for patients choosing generic drugs

Ceritinib (Ceritinib) is a targeted therapy for ALK-positive non-small cell lung cancer and is widely used in the clinical treatment of patients. Regarding the price of the Indian version of ceritinib, there is currently no Indian version of the generic drug on the market, which means that patients cannot purchase the drug in generic form through Indian channels. Due to the lack of Indian generic drugs, patients mainly rely on domestic original drugs or generic versions of drugs from other countries when choosing drugs.

In China, ceritinib has been officially launched and included in the medical insurance catalog. Patients can purchase the drug through medical insurance channels in major hospitals or pharmacies, thereby enjoying more favorable prices and reimbursement benefits. The specific price and medical insurance reimbursement ratio will vary depending on the region. Therefore, patients should consult the local hospital or pharmacy before purchasing to obtain accurate price information and medical insurance policies to ensure that the financial burden is within an affordable range.

In addition to the domestic market, the generic version of ceritinib produced in Laos has become an affordable option that patients are paying attention to. The price of the Lao version of ceritinib is about more than 1,000 yuan, which has obvious advantages over the price of domestic original drugs. It is worth noting that the ingredients of Laos’ generic drugs are basically the same as those of the original drugs. On the basis of ensuring efficacy and safety, they provide patients with a lower-cost medication plan.

To sum up, when patients choose ceritinib, although there are no generic drugs in India, the domestic original drug has become the first choice because it is included in medical insurance. If patients are sensitive to drug prices, they can consider obtaining Lao generic drugs through formal channels, but the quality and legality of the drugs must be ensured. No matter which version is chosen, patients should use the medication rationally under the guidance of a doctor to ensure treatment effectiveness and medication safety.

Reference materials:https://www.novartis.com/our-products/pipeline/ceritinib